Drug Database
Back to search

Belgium· BE-AMP-SAM331737-00

Cervarix

A humaner papillomvirus (typen 16, 18) product containing human papillomavirus, types 16,18, registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 10 of our 19 countries.

ATC J07BM02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCervarixATCJ07BM02REGISTER NO.BE-AMP-SAM331737-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about human papillomavirus, types 16,18Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Humaner papillomvirus (typen 16, 18) is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BM02 (humaner papillomvirus (typen 16, 18)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search humaner papillomvirus (typen 16, 18) products by name

Humaner papillomvirus (typen 16, 18) · ATC J07BM02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Papillomavirus, Types 16,18
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07BM02
ATC class
Humaner Papillomvirus (Typen 16, 18)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BM02

Humaner papillomvirus (typen 16, 18), as other registers publish it.

All humaner papillomvirus (typen 16, 18) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7a8b2548-5cc9-4b53-b9aa-ae755317e97e
GET /v1/drugs/7a8b2548-5cc9-4b53-b9aa-ae755317e97e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in multidose container",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Cervarix",
  "name_fr": "Cervarix",
  "name_nl": "Cervarix",
  "amp_code": "SAM331737-00",
  "strengths": null,
  "pack_count": 3,
  "substances": [
    "Human Papillomavirus, Types 16,18",
    "Sodium Dihydrogen Phosphate Dihydrate",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Papillomavirus (human types 16, 18)",
  "authorisation_numbers": [
    "EU/1/07/419/010",
    "EU/1/07/419/011",
    "EU/1/07/419/012"
  ]
}
API referenceMCP serverPlans

See everything about humaner papillomvirus (typen 16, 18).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console